Overview
- Spanberger, who signed four bipartisan bills Monday, said the measures authorize incentives tied to about 3,250 jobs and $7.1 billion in corporate investment.
- The legislation covers projects from Avio USA, Hitachi Energy, Eli Lilly, and AstraZeneca, which include rocket motor manufacturing, grid equipment, and pharmaceutical production.
- Reporters noted the companies announced these commitments in late 2025 during Glenn Youngkin’s term, with press releases quoting him and executives praising his team’s role.
- Spanberger’s critics say she claimed credit for deals secured earlier, while her allies point out the current administration and legislature completed the formal incentive approvals.
- Economic development often unfolds in stages, with site selections and company announcements coming first and funding or awards authorized later, a process that can span administrations; the clash also lands as a new poll pegs Spanberger’s approval at 47% with concerns about affordability.